טוען...
Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study published in Clinical Cancer Research, we demonstra...
שמור ב:
| הוצא לאור ב: | Integr Cancer Ther |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247554/ https://ncbi.nlm.nih.gov/pubmed/30229677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735418801524 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|